e-learning
resources
Vienna 2012
Tuesday, 04.09.2012
Genetics and genomics in asthma and COPD: prediction and personalised medicine
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Predictive and personalised medicine for asthma using genomics
S. Weiss (Boston, United States of America)
Source:
Annual Congress 2012 - Genetics and genomics in asthma and COPD: prediction and personalised medicine
Session:
Genetics and genomics in asthma and COPD: prediction and personalised medicine
Session type:
Symposium
Number:
3056
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Weiss (Boston, United States of America). Predictive and personalised medicine for asthma using genomics. Annual Congress 2012 - Genetics and genomics in asthma and COPD: prediction and personalised medicine
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Biomarkers and personalised medicine for asthma
Source: Eur Respir J, 53 (1) 1802094; 10.1183/13993003.02094-2018
Year: 2019
The future of personalised medicine in COPD
Source: International Congress 2016 – Endotyping: the means to personalised medicine in lung disease
Year: 2016
Diagnosing asthma in the era of personalised medicine: biology, physiology and imaging
Source: Virtual Congress 2021 – Precision medicine in asthma and COPD
Year: 2021
In the era of personalized medicine, what are the current unmet needs in asthma?
Source: International Congress 2019 – The journey towards personalized medicine in asthma: where are we now?
Year: 2019
Asthma susceptibility: from pathophysiology to personalised medicine
Source: International Congress 2015 – ME4 Asthma susceptibility
Year: 2015
A personalised medicine approach to ICS use in COPD
Source: International Congress 2019 – Personalised medicine in COPD: Matching the patient needs with the right care
Year: 2019
Personalised medicine in asthma: from curative to preventive medicine
Source: Eur Respir Rev 2017; 26: 160010
Year: 2017
Proteomic research tools for respiratory medicine
Source: Annual Congress 2008 - PG8 - Cellular and molecular technologies of today - treatments of tomorrow
Year: 2008
Evaluation of the use of e-learning in training management of asthma and COPD in general medicine.
Source: International Congress 2017 – Medical education, web and internet
Year: 2017
Computational challenges of personalised medicine: from bench to bedside
Source: Virtual Congress 2021 – Digital transformation in practice: enabling next-generation medicine
Year: 2021
Personalised medicine through biological subphenotyping of ARDS
Source: Virtual Congress 2021 – Acute respiratory distress syndrome phenotypes: implications for diagnosis and treatment
Year: 2021
Spatial transcriptomics for respiratory research and medicine
Source: Eur Respir J, 58 (1) 2004314; 10.1183/13993003.04314-2020
Year: 2021
Personalised medicine in paediatric asthma, including from the patient's perspective
Source: International Congress 2016 – PG8 Paediatric asthma
Year: 2016
Personalised medicine in exacerbations of COPD: the beginnings
Source: Eur Respir J 2012; 40: 1318-1319
Year: 2012
The basic science behind asthma biologics
Source: International Congress 2018 – New biologics for asthma: which patients, which agents, which results, at what cost?
Year: 2018
What is evidence-based medicine?
Source: Annual Congress 2006 - PG16 - The use of evidence-based medicine and practice for the clinician (jointly organised with the ACCP)
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept